| Literature DB >> 33214678 |
Lidiane G Silva1, Ana F S Péres2,3, Daniel L D Freitas1, Camilo L M Morais4, Francis L Martin5, Janaina C O Crispim2,3, Kassio M G Lima6.
Abstract
The primary concern for HIV-infected pregnant women is the vertical transmission that can occur during pregnancy, in the intrauterine period, during labour or even breastfeeding. The risk of vertical transmission can be reduced by early diagnosis. Therefore, it is necessary to develop new methods to detect this virus in a quick and low-cost fashion, as colorimetric assays for HIV detection tend to be laborious and costly. Herein, attenuated total reflection Fourier-transform infrared (ATR-FTIR) spectroscopy combined with multivariate analysis was employed to distinguish HIV-infected patients from healthy uninfected controls in a total of 120 blood plasma samples. The best sensitivity (83%) and specificity (92%) values were obtained using the genetic algorithm with linear discriminant analysis (GA-LDA). These good classification results in addition to the potential for high analytical frequency, the low cost and reagent-free nature of this method demonstrate its potential as an alternative tool for HIV screening during pregnancy.Entities:
Mesh:
Year: 2020 PMID: 33214678 PMCID: PMC7677535 DOI: 10.1038/s41598-020-77378-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Infrared (IR) spectra. (A) Mean raw IR spectra in the bio-fingerprint region (1800–900 cm−1) for HIV-infected (HIV) and healthy uninfected controls (HC) samples. (B) Mean pre-processed IR spectra (AWLS baseline correction) in the bio-fingerprint region (1800–900 cm−1) for HIV-infected (HIV) and healthy uninfected controls (HC) samples.
Study participant information and demographics.
| Group | ||
|---|---|---|
| Case (HIV-infection) | Control uninfected | |
| Age (mean ± SD) | 28 ± 6 | 31 ± 6 |
| Gestational age (weeks ± SD) | 21 ± 7 | 24 ± 7 |
| Smoking, | ||
| Yes | 4 (10.3%) | 0 |
| No | 35 (89.7%) | 35 (100%) |
| Drugs use, | ||
| Yes | 7 (18%) | 3 (8.57%) |
| No | 32 (82%) | 33 (94.3%) |
Quality parameters calculated in the test set to classify healthy uninfected controls vs. HIV-infected samples.
| Model | AC | SENS | SPEC | F-Score | G-Score |
|---|---|---|---|---|---|
| PCA-LDA | 70 | 67 | 71 | 69 | 69 |
| PCA-QDA | 58 | 83 | 46 | 59 | 62 |
| PCA-SVM | 81 | 83 | 79 | 81 | 81 |
| SPA-LDA | 75 | 50 | 88 | 64 | 66 |
| SPA-QDA | 64 | 8 | 92 | 15 | 28 |
| SPA-SVM | 67 | 8 | 96 | 15 | 87 |
| GA-LDA | 89 | 83 | 92 | 87 | 87 |
| GA-QDA | 64 | 8 | 100 | 15 | 29 |
| GA-SVM | 66.7 | 0 | 100 | 0 | 0 |
AC = accuracy, SENS = sensitivity, SPEC = specificity.
Figure 2GA-LDA results. (A) Selected wavenumbers (901, 1506, 1558, 1653 cm−1) responsible for class separation. (B) Discriminant function (DF) for the samples in the test set, where HIV stands for HIV-infected samples and HC for healthy uninfected controls.
Wavenumbers selected by GA-LDA to discriminate healthy uninfected controls vs. HIV-infected samples.
| Selected wavenumber (cm−1) | Tentative assignment |
|---|---|
| 901 | Phosphodiester stretching |
| 1506 | Ring base |
| 1558 | Amide II (N–H bending vibration) |
| 1653 | Amide I (C = O stretching) |
Tentative assignment based on Movasaghi et al.[10].
Equations to calculate the classification quality parameters.
| Parameter | Equation |
|---|---|
| Accuracy (AC) (%) | |
| Sensitivity (SENS) (%) | |
| Specificity (SPEC) (%) | |
| F-Score (%) | |
| G-Score (%) |
TP stands for true positive, TN for true negative, FP for false positive and FN for false negative.